Alcohol craving. Z13.3Special screening examination for mental and behavioural disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults (aged 18 and above) with a diagnosis of alcohol use disorder based on DSM-5 criteria. Having a score above the threshold on scales assessing anxiety, depression, and alcohol craving Ability to understand and sign an informed consent form Absence of other severe neurological or psychiatric disorders (except anxiety and depression) No brain lesions, seizures, or history of brain surgery The patient does not use drugs or any opioid or amphetamine compounds or stimulants (smoking is not prohibited).
Exclusion criteria
Exclusion criteria: Presence of medical conditions that are contraindicated for the use of CES, such as severe heart disease, uncontrolled diabetes, etc. Having implanted electronic devices, such as a pacemaker or hearing amplifier The presence of metal embedded in or near the brain Taking medications that interfere with CES, such as anticoagulants Having severe cognitive impairment or inability to understand instructions Being pregnant or breastfeeding in women Withdrawal from participation in the study at any stage of the research A history of seizures or any brain disease Taking any psychiatric medication except gabapentin Use of any substance other than cigarettes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of temptation to drink alcohol, measured by the Franken Craving Questionnaire. Timepoint: 1. Before the intervention 2. After 4 weeks of intervention. Method of measurement: Patients completed the Franken Craving Questionnaire twice (before and after 4 weeks of intervention). | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression: Hamilton Depression Rating Scale (HDRS) score. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Measurement: Hamilton Depression Rating Scale (HDRS) as an interview by a psychiatrist.;Anxiety questionnaire score (e.g. HADS or BAI). Timepoint: Before and after 4 weeks of intervention. Method of measurement: Anxiety assessment with a standard questionnaire at two points in time. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences